Covid-19 Impact on Grayline – Update

Mar. 26, 2020

As the number of COVID-19 cases continue to rise in the U.S., our pharmaceutical representatives have decided to stall their studies. All this means, is that we cannot recruit new patients, but we are open and here to talk about our studies and take your information for when the studies resume! If you or someone…

Concerning COVID-19

Mar. 19, 2020

At Grayline Research Center, your health is and always will be our top priority. At this time, we are staying updated on all the information regarding the COVID-19 (Coronavirus) outbreaks. We are a low traffic clinic, allowing us to continue our high sensitization routine. Here are the following precautions we take to prevent the spread:…